To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
The Biotechnology Faculty has been created by grouping relevant Sections from other F1000 Faculties, it therefore does not have separate Heads of Faculty, Section Heads or Faculty Members.
This article describes the recombinant production of mammalian tubulin, specifically alpha1 and beta3 tubulin, using a baculovirus expression system. Traditionally, mammalian tubulin is obtained from brain tissue through repeated cycles of polymerization and depolymerization, but...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Recommendations, most recent by| Interesting Hypothesis | New Finding | Novel Drug Target
Past 7 Days
New Articles Recommended
Past 30 Days
39Articles Classified As Novel Drug Target3,113 total
51Articles Classified As Good for Teaching1,613 total
25Articles Classified As Confirmation4,488 total
12Articles Classified As Review / Commentary802 total
10Articles Classified As Controversial1,735 total
52Articles Classified As Interesting Hypothesis6,708 total
71Articles Classified As Technical Advance10,902 total
197Articles Classified As New Finding25,406 total
4Articles Classified As Refutation272 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.